empty
 
 
pt
Pesquisar
Suporte
Abertura instanânea da conta
Plataforma de negociação
Depósito/Retirada
Pesquisar
Para Iniciantes Para Traders Para Parceiros Relaxe Sobre a InstaSpot
pt
#BMY Voltar à lista de instrumentos #CGC

Conversor de moedas

BioNTech SE
115.35 USD
23 Jan 2026 22:59
Mudança de preço (% chg)
$0.23
(0.2%)
Fechamento anterior
Fechamento anterior

Preço de fechamento, no dia anterior.
$117.74
Abrir
Abrir

Preço de abertura.
$117.21
Máximo do dia
Máximo do dia

O preço mais alto do último dia de negociação.
$118.13
Mínimo do dia
Mínimo do dia

O preço mais baixo do último dia de negociação
$114.84
Alta de 52-semanas
Alta de 52-semanas

Faixa de preço alta nas últimas 52 semanas
$118.13
Baixa de 52-semana
Baixa de 52-semana

Faixa de preço baixa nas últimas 52 semanas
$104.47
Baixar arquivo
Buy
115.35
Sell
115.35
Open the chart in full screen view
Buy
115.35
Sell
115.35
Baixar arquivo
Open the chart in full screen view

BioNTech SE. About company

BioNTech SE. is a biotechnology company founded in 2008 in Germany. It develops medicines for the treatment of cancer, HIV, tuberculosis, and other diseases.

In 2020, BioNTech SE. participated in the creation of a COVID-19 vaccine together with Pfizer and Fosun Pharma. As of March 2022, BioNTech SE. and Pfizer have delivered more than 3.1 billion doses of vaccines.

The company owns a factory in Marburg but most of the vaccines are produced at Pfizer and other companies' factories. In 2021, BioNTech SE. announced its plan to open its first vaccine manufacturing facility in Rwanda.

Its market cap currently stands at $33.38 billion. In 2021, its revenue amounted to $18,976 billion. The net profit totaled $10,292 billion.

BioNTech SE. shares and what factors impact them

BioNTech SE. stock has been traded on the NASDAQ exchange under the BNTX ticker since 2019. The initial price was $15.

Nowadays, the stock price is estimated at $135-$138. Over the year, it fluctuated in the range of $117 - $370.

In 2022, the company paid dividends to the shareholders in the amount of $2.11 per share. The yield was 1.65%.

You should pay attention to the following factors when trading its stock:

  • News about rivals that produce medicines and vaccines;
  • Likelihood of a high profit from the development of an Omicron vaccine;
  • Dependence on government agencies that regulate the industry and the production of coronavirus vaccines.

Não pode falar agora?
Faça sua pergunta no chat.